RGC Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

14.850

Open

14.550

VWAP

12.92

Vol

380.69K

Mkt Cap

8.29B

Low

11.890

Amount

4.92M

EV/EBITDA(TTM)

--

Total Shares

495.47M

EV

5.95B

EV/OCF(TTM)

--

P/S(TTM)

--

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Show More

Events Timeline

(ET)

2026-06-17

12:30:00

Regencell Bioscience Shares Down 14.7% to $14.27

2026-04-07 (ET)

2026-04-07

12:10:00

Regencell Bioscience Shares Down 10.7% to $27.52

2026-04-07

10:10:00

Regencell Bioscience Shares Down 7.1% to $28.64

2026-04-02 (ET)

2026-04-02

12:10:00

Regencell Bioscience Shares Down 9.5% to $30.50

2026-04-01 (ET)

2026-04-01

12:10:00

Regencell Bioscience Stock Rises 49.5% to $38.02

2026-04-01

10:10:00

Regencell Bioscience Stock Rises 23.9% to $31.50

2026-03-30 (ET)

2026-03-30

06:20:00

Regencell Bioscience Files to Sell Ordinary Shares

2026-03-23 (ET)

2026-03-23

12:10:00

Regencell Bioscience Shares Down 8.7% to $25.00

2026-03-18 (ET)

2026-03-18

12:10:00

Regencell Bioscience Stock Rises 15.4% to $26.50

2026-03-18

10:10:00

Regencell Bioscience Stock Rises 26.7% to $29.11

News

Yahoo Finance

06-18Yahoo Finance

PinnedRelevant Gold Corp. Announces Shareholder Meeting Voting Results

PRnewswire

06-19PRnewswire

Faruqi & Faruqi Encourages Regencell Investors to Reach Out

Globenewswire

06-18Globenewswire

Regencell Securities Class Action Notice

Globenewswire

06-18Globenewswire

Multiple Companies Face Class Action Lawsuits

PRnewswire

06-18PRnewswire

Regencell Bioscience Faces Class Action Over Alleged Misrepresentations

PRnewswire

06-18PRnewswire

Regencell Securities Class Action Reminder

Valuation Metrics

The current forward P/E ratio for Regencell Bioscience Holdings Ltd (RGC.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Regencell Bioscience Holdings Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

ARE QUANTUM STOCKS GOING DOWN

Intellectia · 29 candidates

Rsi Category: moderateRelative Vol: >= 1.50Moving Average Relationship: PriceBelowMA20, PriceBelowMA200Month Price Change Pct: <= $0.00Ema 20: >= -100Ema 60: >= -100Monthly Average Dollar Volume: >= 1,000,000Macd: bearish

Ticker

Name

Market Cap$

WORK Medical Technology Group Ltd

191.43K

Lichen International Ltd

17.75M

Zepp Health Corp

129.05M

Futu Holdings Ltd

15.10B

UP Fintech Holding Ltd

894.39M

Corbus Pharmaceuticals Holdings Inc

210.29M

okay give me some I can buy

Intellectia · 8 candidates

Market Cap: >= 10.00BRegion: USPrice: $5.00 - $60.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Month Price Change Pct: >= $20.00Monthly Average Dollar Volume: >= 5,000,000

Ticker

Name

Market Cap$

Planet Labs PBC

11.85B

Amkor Technology Inc

13.66B

SK Telecom Co Ltd

13.67B

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP

23.76B

Stellantis NV

29.78B

Regencell Bioscience Holdings Ltd

13.93B

stick of the week

Intellectia · 10 candidates

Market Cap: >= 10.00BRsi Category: moderateMoving Average Relationship: PriceAboveMA200Week Price Change Pct: >= $10.00Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Planet Labs PBC

12.12B

SBA Communications Corp

22.64B

Intel Corp

254.58B

Seagate Technology Holdings PLC

96.19B

Ciena Corp

61.40B

Lumentum Holdings Inc

55.14B

what should I buy for swing trading

Intellectia · 426 candidates

Price: $10.00 - $150.00Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Month Price Change Pct: $5.00 - $40.00Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Moolec Science SA

5.05M

Aehr Test Systems

1.36B

Blacksky Technology Inc

1.14B

Intuitive Machines Inc

5.20B

Korro Bio Inc

201.92M

Sensei Biotherapeutics Inc

41.58M

top moving stocks

Intellectia · 31 candidates

Market Cap: >= 500.00MPrice: >= $2.00Price Change Pct: $-100.00 - $-5.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 500,000

Ticker

Name

Market Cap$

Lindsay Corp

1.22B

Knife River Corp

4.65B

Omeros Corp

869.71M

Wix.Com Ltd

5.28B

Ironwood Pharmaceuticals Inc

635.93M

Prestige Consumer Healthcare Inc

2.73B

stocks gain $5.00 in 2026

Intellectia · 2622 candidates

Year Price Change Pct: >= $0.01

Ticker

Name

Market Cap$

AXT Inc

3.80B

Palatin Technologies Inc

35.18M

Regencell Bioscience Holdings Ltd

12.08B

Relmada Therapeutics Inc

639.83M

Babcock & Wilcox Enterprises Inc

1.95B

Terns Pharmaceuticals Inc

5.44B

bullish stocks this week

Intellectia · 56 candidates

Market Cap: >= 4.00BRegion: USList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: >= $10.00Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Masimo Corp

9.43B

Immunitybio Inc

8.41B

Ondas Inc

4.98B

Moderna Inc

18.21B

elf Beauty Inc

5.20B

Kratos Defense and Security Solutions Inc

17.84B

ابي سهم التارقت حقي يكون اجيب فوق 25% واعلى من راس مالي

Intellectia · 1346 candidates

Year Price Change Pct: >= $25.00

Ticker

Name

Market Cap$

Regencell Bioscience Holdings Ltd

13.54B

Palatin Technologies Inc

28.78M

Rich Sparkle Holdings Ltd

875.38M

Abivax SA

8.86B

Sandisk Corp

97.55B

Hycroft Mining Holding Corporation

3.20B

what’s a good buy for day trading

Intellectia · 2418 candidates

Region: USPrice: $2.00 - $200.00Volume: >= 200,000List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

AstraZeneca PLC

298.35B

Planet Green Holdings Corp

30.35M

Aquestive Therapeutics Inc

509.36M

Perspective Therapeutics Inc

351.47M

Ascent Solar Technologies Inc

29.36M

PAVmed Inc

9.16M

entonces que acciones?

Intellectia · 74 candidates

Market Cap: >= 3.00BRsi Category: moderateWeek Price Change Pct: $5.00 - $20.00Ema 20: >= -100Ema 60: >= -100Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Sasol Ltd

4.76B

Lemonade Inc

6.97B

Telecom Argentina SA

5.50B

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP

18.55B

Korea Electric Power Corp

27.73B

Posco Holdings Inc

19.18B

Whales Holding RGC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Regencell Bioscience Holdings Ltd (RGC) stock price today?

The current price of RGC is 12.01 USD — it has decreased -18.96

What is Regencell Bioscience Holdings Ltd (RGC)'s business?

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

What is the price predicton of RGC Stock?

Wall Street analysts forecast RGC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RGC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Regencell Bioscience Holdings Ltd (RGC)'s revenue for the last quarter?

Regencell Bioscience Holdings Ltd revenue for the last quarter amounts to NaN USD, decreased

What is Regencell Bioscience Holdings Ltd (RGC)'s earnings per share (EPS) for the last quarter?

Regencell Bioscience Holdings Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Regencell Bioscience Holdings Ltd (RGC). have?

Regencell Bioscience Holdings Ltd (RGC) has 10 emplpoyees as of June 20 2026.

What is Regencell Bioscience Holdings Ltd (RGC) market cap?

Today RGC has the market capitalization of 8.29B USD.